Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (2050702)
Medical Research Foundation (MR/S028188/1)
Received: 22 April 2022
Accepted: 11 July 2022
First Online: 30 August 2022
: Ethical approval for the UK Biobank study has been granted by the National Information Governance Board for Health and Social Care and the NHS North West Multicentre Research Ethics Committee (11/NW/0382). No project-specific ethical approval is needed. Data access permission has been granted under UK Biobank application 45514. Participants consented to use of their de-identified data.
: Not applicable.
: JM receives studentship funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Eli Lilly and Company Limited. AD, UC and JZ declare no relevant conflict of interest.